Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03591367
What this trial is testing

The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation

Who this might be right for
Bladder CancerBladder DiseaseBladder Neoplasm+1 more
Mansoura University 115
Not applicableEnded earlyNCT02145390
What this trial is testing

Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Bladder CancerBladder CarcinomaTransition Cell Cancer+1 more
University of Miami 1
Testing effectiveness (Phase 2)Ended earlyNCT01625260
What this trial is testing

ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Altor BioScience 12
Not applicableEnded earlyNCT01954173
What this trial is testing

Adjuvant Radiation for High Risk Bladder Cancer

Who this might be right for
Bladder CancerSquamous Cell Carcinoma of the BladderStage III Bladder Cancer+2 more
Emory University 19
Large-scale testing (Phase 3)Active Not RecruitingNCT06462001
What this trial is testing

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaTransurethral Resection
Nottingham University Hospitals NHS Trust 500
Not applicableUnknownNCT04966130
What this trial is testing

Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder.

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 96
Not applicableUnknownNCT05671900
What this trial is testing

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
Clinical Hospital Centre Zagreb 70
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783153
What this trial is testing

Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients

Who this might be right for
Radiotherapy Induced DiarrheaAcute Radiation EnteritisProstate Cancer+5 more
Mansoura University 80
Early research (Phase 1)UnknownNCT04134000
What this trial is testing

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Who this might be right for
Invasive Bladder Cancer
Fundacion Oncosur 40
Early research (Phase 1)Study completedNCT00648102
What this trial is testing

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

Who this might be right for
Breast CancerColorectal CancerPancreatic Cancer+2 more
Celldex Therapeutics 36
Testing effectiveness (Phase 2)UnknownNCT02422277
What this trial is testing

Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy

Who this might be right for
Bladder Cancer
Mansoura University 60
Not applicableUnknownNCT03362801
What this trial is testing

SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly

Who this might be right for
SarcopeniaBladder Cancer
University Hospital, Caen 69
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01342172
What this trial is testing

Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma

Who this might be right for
Urinary Bladder Neoplasms
Icahn School of Medicine at Mount Sinai 9
Not applicableUnknownNCT01033682
What this trial is testing

Evaluation of Bladder Volumes in Patients Receiving Radiotherapy to the Rectum, Using Kilovoltage Cone-beam Imaging

Who this might be right for
Rectal Cancer
Royal Marsden NHS Foundation Trust 10
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Not applicableStudy completedNCT02252445
What this trial is testing

Propofol and Sevoflurane for Catheter-Related Bladder Discomfort

Who this might be right for
Catheter Site DiscomfortComplicationsAnesthesia+1 more
Seoul National University Hospital 82
Early research (Phase 1)Study completedNCT06100653
What this trial is testing

BCG for Therapeutic Use Phase I Clinical Trial

Who this might be right for
Non-muscular Invasive Bladder Cancer
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 10
Testing effectiveness (Phase 2)WithdrawnNCT04040725
What this trial is testing

Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression

Who this might be right for
Bladder Cancer
Dana-Farber Cancer Institute
Next Page